Stanford University
Showing 1,311-1,320 of 1,477 Results
-
ashley dudarenok
Affiliate, Graduate School of Business - Executive Education
BioAshley Dudarenok is a Chinese entrepreneur, author, and media personality, recognised by Thinkers50 as a “guru on fast‑evolving trends in China.” She is the founder of ChoZan, an immersive executive education company that helps Fortune 500 leaders learn from China’s digital transformation and innovation ecosystem.
Through China Innovation Tours, executive immersions, and strategic briefings, Ashley and her team provide senior leaders with firsthand access to China’s most innovative companies. ChoZan also delivers proprietary insights, market research, and tailored learning programmes focused on digital transformation, consumer trends, and next‑generation technologies.
Ashley is a sought‑after keynote speaker and the author of several bestselling books on China’s digital economy. She runs a widely read newsletter and engages a B2B community of over 500,000 global China watchers across LinkedIn and YouTube. Her latest venture, The Hidden Switch, spotlights billion‑dollar founders from emerging markets who are reshaping the world. -
Ramzi Emanuel Dudum
Member (Postdoc), Cardiovascular Institute
BioDr. Dudum is a cardiologist and population health expert working to develop novel risk prediction methods and implementation strategies to create practices and systems that allow for reductions in cardiovascular disease. He completed a Masters in Public Health at Johns Hopkins concentrating in epidemiology and biostatistics and a Doctorate of Medicine at George Washington University.
He completed internal medicine residency training as part of the Osler Medical Service, where he worked under the mentorship of Drs. Roger Blumenthal and Michael Blaha to study improving cardiovascular risk prediction and coronary artery calcium. Given his focus on population health and implementation science, he also helped launch and refine risk adjustment tools and implemented guideline-directed medical care pathways. During his time there, he was recognized for his clinical acumen and dedication to patient care.
He came to Stanford for his cardiovascular medicine fellowship and continued research in coronary artery calcium under the mentorship of Drs. David Maron and Fatima Rodriguez while also conducting cardiovascular health implementation science work under the mentorship of Dr. Steve Asch. He serves as the co-investigator of a prospective randomized trial testing the effects of notification of incidental coronary artery calcium on statin initiation rates among those with and without cardiovascular disease (NCT 05588895). He has worked with hospital leaders to implement digital health and artificial intelligence tools, creating the infrastructure for the prospective use of AI-algorithms on radiology studies. As a preventive cardiologist and population health expert, he leads efforts in the preventive cardiology section related to improving cardiovascular health.
